Michael Asger Andersen (Michael A Andersen)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Machine Learning

Newly Diagnosed

Chronic Lymphocytic Leukemia

Signaling Pathway

Top Venues

European journal of haematology

Clinical cancer research : an official journal of the American Association for Cancer Research

British journal of haematology

Acta oncologica (Stockholm, Sweden)

This page only lists publications with an associated author ORCID identifier.

Publications

Anders Peder Højer Karlsen, Pernille Bjersand Sunde, Markus Harboe Olsen, Jens Laigaard, Caroline Folkersen, Trang Xuan Minh Tran, Ida Houtved Rasmussen, Selma Kjartansdóttir, Atena Saito, Michael Asger Andersen, Mathias Maagaard, Nicholas Papadomanolakis-Pakis, Kim Peder Dalhoff, Lone Nikolajsen, Troels Haxholdt Lunn, Christian Sahlholt Meyhoff, Janus Christian Jakobsen, Ole Mathiesen
Opioids and personalized analgesia in the perioperative setting: A protocol for five systematic reviews. Acta anaesthesiologica Scandinavica (2024)
Noomi Vainer, Kathrine Aarup, Michael Asger Andersen, Lise Wind-Hansen, Tine Nielsen, Henrik Frederiksen, Lisbeth Enggaard, Christian Bjørn Poulsen, Carsten Utoft Niemann, Emelie Curovic Rotbain
Real-world outcomes upon second-line treatment in patients with chronic lymphocytic leukaemia. British journal of haematology (2023)
Christian Brieghel, Veerle Galle, Rudi Agius, Caspar da Cunha-Bang, Michael Asger Andersen, Philip Vlummens, Mattias Mattsson, Richard Rosenquist, Karin E Smedby, Carmen D Herling, Jasmin Bahlo, Michael Hallek, Jens Dilling Lundgren, Fritz Offner, Carsten Utoft Niemann
Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait? European journal of haematology 108 (5) (2022)
Christian Brieghel, Kathrine Aarup, Mathias Husted Torp, Michael Asger Andersen, Christina W Yde, Xin Tian, Adrian Wiestner, Inhye E Ahn, Carsten Utoft Niemann
Clinical Outcomes in Patients with Multi-Hit TP53 Chronic Lymphocytic Leukemia Treated with Ibrutinib. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (16) (2021)
Fie Juhl Vojdeman, Jens Helby, Lone B Pedersen, Christian Brieghel, Michael Asger Andersen, Børge G Nordestgaard, Stig Egil Bojesen, Carsten Utoft Niemann
Chronic lymphocytic leukaemia clones are detectable decades before diagnosis. British journal of haematology (2021)
Michael Asger Andersen, Klaus Rostgaard, Carsten Utoft Niemann, Henrik Hjalgrim
Antimicrobial use before chronic lymphocytic leukemia: a retrospective cohort study. Leukemia 35 (3) (2020)
Christian Brieghel, Caspar da Cunha-Bang, Christina Westmose Yde, Ane Yde Schmidt, Savvas Kinalis, Ferran Nadeu, Michael Asger Andersen, Line Offenbach Jacobsen, Lone Bredo Pedersen, Julio Delgado, Tycho Baumann, Mattias Mattsson, Larry Mansouri, Richard Rosenquist, Elias Campo, Finn Cilius Nielsen, Carsten Utoft Niemann
The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease Outcome. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (6) (2020)
Rudi Agius, Christian Brieghel, Michael Asger Andersen, Alexander T Pearson, Bruno Ledergerber, Alessandro Cozzi-Lepri, Yoram Louzoun, Christen L Andersen, Jacob Bergstedt, Jakob H von Stemann, Mette Jørgensen, Man-Hung Eric Tang, Magnus Fontes, Jasmin Bahlo, Carmen D Herling, Michael Hallek, Jens Dilling Lundgren, Cameron Ross MacPherson, Jan Larsen, Carsten Utoft Niemann
Machine learning can identify newly diagnosed patients with CLL at high risk of infection. Nature communications 11 (1) (2020)
Kathrine Aarup, Emelie Curovic Rotbain, Lisbeth Enggaard, Robert Schou Pedersen, Olav Jonas Bergmann, Rasmus Heje Thomsen, Mikael Frederiksen, Henrik Frederiksen, Tine Nielsen, Ilse Christiansen, Michael Asger Andersen, Carsten Utoft Niemann
Real-world outcomes for 205 patients with chronic lymphocytic leukemia treated with ibrutinib. European journal of haematology 105 (5) (2020)
Michael Asger Andersen, Rebecca Valentin, Lene Dissing Sjö, Line Borgwardt, Kjeld Schmiegelow, Mette Klarskov Andersen, Rasmus L Marvig, Christina Westmose Yde, Carsten Utoft Niemann
Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia. A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma. Acta oncologica (Stockholm, Sweden) 59 (12) (2020)